apixaban
1 clinical trial
1 product
7 abstracts
4 indications
Indication
Deep Vein ThrombosisIndication
Upper Extremity Deep Venous ThrombosisIndication
ThrombusIndication
Venous ThromboembolismAbstract
Apixaban versus warfarin for primary thromboprophylaxis in patients with multiple myeloma undergoing immunomodulatory treatment.Org: Mount Auburn Hospital, Unity Hospital, Rochester Regional Health, National Cheng Kung University College of Medicine, Tainan,
Abstract
Efficacy of low-dose direct oral anticoagulants (DOACs) for venous thromboembolism prophylaxis in newly diagnosed multiple myeloma.Org: Cleveland Clinic Taussig Cancer Instititute,
Clinical trial
Apixaban for Routine Management of Upper Extremity Deep Venous ThrombosisStatus: Terminated, Estimated PCD: 2021-11-11
Abstract
Evaluation of bleeding risk between apixaban and rivaroxaban in patients with gastrointestinal cancer.Org: Emory University Hospital Midtown, Winship Cancer Institute of Emory University, Dana-Farber Cancer Institute, Astellas Pharma, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, Winship Cancer Institute of Emory University, Atlanta, GA, Emory University, Atlanta, GA, Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, Department of Medicine, Massachusetts General Hospital, Boston, MA, Department of Medicine, Emory University School of Medicine, Atlanta, GA, Department of Urology, Emory University School of Medicine, Atlanta, GA,
Abstract
Anticoagulation for portal vein thrombosis in patients with hepatocellular carcinoma: A retrospective observational study.Org: Trinity Health of New England, Corewell Health System - Beaumont University Hospital, William Beaumont University Hospital,
Abstract
Apixaban versus rivaroxaban for treatment of acute deep venous thrombosis in patients with cancer.Org: Department of Biochemistry and Molecular Biology, University of Texas Medical Branch at Galveston, Alara Medical Group,
Abstract
Real world data for venous thromboembolisms (VTEs) in patients with active cancer: Thromboprophylaxis pooled analysis from GMaT and ACT4CAT studies.Org: Hellenic Society of Medical Oncology, HeSMO,
Abstract
Anticoagulation prescribing practices in high-risk, under-represented patients with malignancy and venous thromboembolism (VTE).Org: Temple University Hospital, Philadelphia, PA,
Product
Anticoagulation